2023 - Research.com Microbiology in United States Leader Award
2010 - Alexander Fleming Award, Infectious Diseases Society of America
2007 - Maxwell Finland Award for Scientific Achievement, National Foundation for Infectious Diseases
Member of the Association of American Physicians
His scientific interests lie mostly in Diarrhea, Microbiology, Internal medicine, Traveler's diarrhea and Surgery. Herbert L. DuPont interconnects Enterotoxigenic Escherichia coli, Feces, Enteroaggregative Escherichia coli, Etiology and Shigellosis in the investigation of issues within Diarrhea. His studies in Microbiology integrate themes in fields like Virology, Shigella, Escherichia coli, Immunology and Virulence.
His research integrates issues of Gastroenterology, Clostridium difficile, Placebo and Rifaximin in his study of Internal medicine. His Traveler's diarrhea research incorporates themes from Sulfamethoxazole, Chemoprophylaxis, Trimethoprim, Prevalence and Azithromycin. Herbert L. DuPont has researched Surgery in several fields, including Incidence and Risk factor.
His primary areas of study are Diarrhea, Microbiology, Internal medicine, Immunology and Virology. He studies Diarrhea, namely Traveler's diarrhea. His study focuses on the intersection of Traveler's diarrhea and fields such as Trimethoprim with connections in the field of Antimicrobial.
His work in Microbiology addresses issues such as Escherichia coli, which are connected to fields such as Bacteria. His work deals with themes such as Gastroenterology, Clostridium difficile, Placebo and Surgery, which intersect with Internal medicine. His Clostridium difficile course of study focuses on Epidemiology and Etiology.
His primary areas of investigation include Clostridium difficile, Internal medicine, Microbiology, Diarrhea and Antibiotics. The Clostridium difficile study combines topics in areas such as Feces, Surgery and Metronidazole. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Placebo.
His work focuses on many connections between Gastroenterology and other disciplines, such as Rifaximin, that overlap with his field of interest in Rifamycin. His Microbiology research includes themes of Gut flora, Escherichia coli and Virulence. Specifically, his work in Diarrhea is concerned with the study of Traveler's diarrhea.
His primary scientific interests are in Diarrhea, Clostridium difficile, Microbiology, Internal medicine and Immunology. His research on Diarrhea focuses in particular on Traveler's diarrhea. Herbert L. DuPont combines subjects such as Feces, Fidaxomicin, Surgery, Metronidazole and Pediatrics with his study of Clostridium difficile.
His Microbiology research includes elements of Gut flora and Pathogenesis. As a part of the same scientific family, Herbert L. DuPont mostly works in the field of Internal medicine, focusing on Gastroenterology and, on occasion, Excretion and Pathophysiology. As a part of the same scientific study, Herbert L. DuPont usually deals with the Immunology, concentrating on Microbiome and frequently concerns with Faecal microbiota transplantation, Clinical trial and Microbial diversity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Practice Guidelines for the Management of Infectious Diarrhea
Richard L. Guerrant;Thomas Van Gilder;Ted S. Steiner;Nathan M. Thielman.
Clinical Infectious Diseases (2001)
The Infectivity of Cryptosporidium parvum in Healthy Volunteers
Herbert L. DuPont;Herbert L. DuPont;Cynthia L. Chappell;Charles R. Sterling;Pablo C. Okhuysen.
The New England Journal of Medicine (1995)
Pathogenesis of Escherichia coli diarrhea.
Herbert L. DuPont;Samuel B. Formal;Richard B. Hornick;Merrill J. Snyder.
The New England Journal of Medicine (1971)
Typhoid Fever: Pathogenesis and Immunologic Control
R. B. Hornick;S. E. Greisman;T. E. Woodward;Herbert L Dupont.
The New England Journal of Medicine (1970)
Inoculum Size in Shigellosis and Implications For Expected Mode of Transmission
Herbert L. DuPont;Myron M. Levine;Richard B. Hornick;Samuel B. Formal.
The Journal of Infectious Diseases (1989)
Virulence of three distinct Cryptosporidium parvum isolates for healthy adults.
Pablo C. Okhuysen;Cynthia L. Chappell;Joseph H. Crabb;Charles R. Sterling.
The Journal of Infectious Diseases (1999)
Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966.
Herbert L. DuPONT;Wesley W. Spink.
Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection.
C. Bavishi;Herbert L Dupont.
Alimentary Pharmacology & Therapeutics (2011)
Infections of the Gastrointestinal Tract
Herbert L. DuPont;Larry K. Pickering.
Prevention and Treatment of Traveler's Diarrhea
Herbert L. DuPont;Charles D. Ericsson.
The New England Journal of Medicine (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: